Primary-CHARM

There is 1 paper on primary-CHARM in aging research: 1 observational study in people.

Biomarker

1 paper studies it2 findings

See all 1 papers on primary-CHARM

“Primary-CHARM scores were independently associated with higher NRM (hazard ratio [HR], 2.72; P < .0001)”
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704Blood advances2025doi:10.1182/bloodadvances.2025015793
  • Humans1

Associations

2

Overall survival

downin humans1HR 2.09

1 study
  1. Primary-CHARM is associated with overall survival in humans (allogeneic hematopoietic cell transplantation for hematologic malignancies) (HR 2.09, P < .0001).

    “Primary-CHARM scores were independently associated with higher NRM (hazard ratio [HR], 2.72; P < .0001) and worse OS (HR, 2.09; P < .0001).”

    Humansallogeneic hematopoietic cell transplantation for hematologic malignancies1 yearn = 1,105

    Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

    Blood advances

Nonrelapse mortality

upin humans1HR 2.72

1 study
  1. Primary-CHARM is associated with nonrelapse mortality in humans (allogeneic hematopoietic cell transplantation for hematologic malignancies) (HR 2.72, P < .0001).

    “Primary-CHARM scores were independently associated with higher NRM (hazard ratio [HR], 2.72; P < .0001)”

    Humansallogeneic hematopoietic cell transplantation for hematologic malignancies1 yearn = 1,105

    Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

    Blood advances

Latest